Latest filing published 25 Oct 2021 for Albireo Pharma, INC., €2,356. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Patrick Taylor Horn in Albireo Pharma, Inc., where the filings describe the role as senior executive. We count 2 filings; the first trade dates from 22 July 2021 and the latest from 22 October 2021.
On the market, this insider has only sold: 2 sales, €4,965 in total.
The newest entry dates from 25 October 2021: an open-market sale of €2,356, in Albireo Pharma, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations